CABAVSGTBP• 6 Months (Normalized)
CABA vs GTBP (Cabaletta Bio Inc. vs GT Biopharma Inc.)
Showing Closing Date Range from Apr 10 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CABA Performance $1.97
-37.06%
Cabaletta Bio Inc.
Normalized Baseline0.00%
GTBP Performance $6.37
+%
GT Biopharma Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
-37.06 pts
GTBP outperforming by 37.06 percentage points
CABAGTBP
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CABA GTBP
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(125 dates)
| Date | CABA Price | CABA Gain (%) | GTBP Price | GTBP Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $1.97 | -37.06% | $- | - | |
| Oct 06, 2026 | $2.02 | -35.46% | $6.37 | +1626.29% | -1661.75% |
| Oct 05, 2026 | $2.08 | -33.55% | $6.16 | +1569.38% | -1602.93% |
| Oct 02, 2026 | $2.00 | -36.10% | $6.10 | +1553.12% | -1589.22% |
| Oct 01, 2026 | $1.89 | -39.62% | $- | - | |
| Sep 30, 2026 | $1.92 | -38.66% | $- | - | |
| Sep 29, 2026 | $1.98 | -36.74% | $6.88 | +1763.14% | -1799.88% |
| Sep 28, 2026 | $2.00 | -36.10% | $6.80 | +1742.82% | -1778.92% |
| Sep 25, 2026 | $2.07 | -33.87% | $6.89 | +1767.21% | -1801.08% |
| Sep 24, 2026 | $2.16 | -31.15% | $6.83 | +1750.95% | -1782.10% |
| Sep 23, 2026 | $2.22 | -29.07% | $7.10 | +1824.12% | -1853.19% |
| Sep 22, 2026 | $2.50 | -20.13% | $- | - | |
| Sep 21, 2026 | $2.46 | -21.41% | $7.18 | +1845.80% | -1867.21% |
| Sep 18, 2026 | $2.55 | -18.53% | $7.16 | +1840.38% | -1858.91% |
| Sep 17, 2026 | $2.58 | -17.57% | $7.49 | +1929.81% | -1947.38% |
Page 1 of 9